BEDFORD, Mass., Feb. 1 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that it has been awarded a three-year contract for its critical care portfolio with Amerinet Inc., a leading health care group purchasing organization. This is the third consecutive contract Amerinet has awarded IL since 2001.
The contract offers more than 37,000 Amerinet members savings on IL's portfolio of critical care analyzers, reagents, consumables and service, including IL's flagship product, the GEM® Premier™ 4000 analyzer for blood gas, CO-Oximetry, electrolyte and metabolite testing. This analyzer features Intelligent Quality Management (iQM®), a real-time, automated, continuous quality assurance system that ensures the quality of every test result and reduces cost and time expenditure. iQM, coupled with its cartridge-based technology and ease of use, allows the GEM Premier 4000 to be used throughout the hospital, at the point of care and in the lab.
"Amerinet understands how important a healthy operating margin is for every health care provider. That's why we partner with all types of providers to create new revenue streams and reduce expenses," said Ken Rosemann, Vice President, Laboratory and Diagnostic Imaging for Amerinet. "This new agreement is one example of our commitment to quality. Over the past nine years, IL has delivered outstanding products and service to Amerinet's members."
"We will continue to provide Amerinet members with savings on the best in critical care diagnostic products," said Brian Durkin, Director Sales and National Accounts at IL. "Our ever-improving and expanding product offering will help Amerinet members stay at the forefront of technology and deliver the highest quality patient care."
In addition to the GEM Premier 4000, IL's contract with Amerinet includes the GEM Premier 3500, GEM OPL, a portable CO-Oximeter; GEMweb, software for remote management of instruments; and GEMweb Plus™, a completely integrated data management system.
As a leading national healthcare group purchasing organization, Amerinet strategically partners with acute and alternate care providers to reduce costs and improve quality through its performance solutions. Built on a foundation of data, savings and trust, and supported by a team of clinical and supply chain experts, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about the Amerinet difference, visit www.amerinet-gpo.com.
Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM® product offerings, part of the critical care line, include the new GEM Premier 3500 with Intelligent Quality Management (iQM®), GEM Premier™ 4000 analyzer, GEMweb Plus information management system, and the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP® Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the ACL TOP, the new ACL TOP LAS and the ACL TOP 500 CTS. IL also offers the new ACL AcuStar™, ACL ELITE® and ELITE PRO, other hemostasis analyzers and the HemosIL® line of reagents. IL is based in Bedford, Massachusetts.
The Instrumentation Laboratory logo, GEM, iQM, HemosIL, ACL TOP, ACL ELITE, ACL AcuStar and Premier are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and Trademark Office and in other jurisdictions. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.
SOURCE Instrumentation Laboratory